ENVB·29405E505·US·equity·Healthcare - Biotechnology-13D/G
ENVB (ENVERIC BIOSCIENCES INC) is held by 8 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($62,368), UBS Group AG ($7,008), JONES FINANCIAL COMPANIES LLLP ($1,880). Net institutional sentiment: Mixed.
See how ENVB's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer